- Home
- / Bioventus
Bioventus
Stock Price
$11.6
2024-09-27
Market Capitalization
$758.8 M
2024-09-27
Revenue
$512.3 M
FY, 2023
Bioventus Summary
Company Summary
- Overview
- Bioventus is a company specializing in orthobiologics and active healing. It provides products for the treatment of bone fractures and chronic pain associated with osteoarthritis. In addition, the company develops orthobiologic surgical solutions for musculoskeletal healing and regeneration.
- Type
- Public
- Status
- Active
- Founded
- 2012
- HQ
- Durham, NC, US | view all locations
- Website
- https://www.bioventus.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Anthony D'Adamio, Senior Vice President and General Counsel
Katrina Church, Chief Compliance Officer
John Nosenzo, Chief Commercial Officer
Operating MetricsView all
Countries
38
Q3, 2020
Products
11
Q3, 2020
LocationsView all
6 locations detected
Durham, NC HQ
United States
Carlisle Place, 4721 Emperor Blvd #100
Santa Clarita, CA
United States
25103 Rye Canyon Loop, Valencia
TN
United States
1900 Charles Bryan Rd #275, Cordova
Mississauga, ON
Canada
100-2476 Argentia Rd
Hod Hasharon, Center District
Israel
Ha-Nagar St 8
Hoofddorp, NH
Netherlands
Taurusavenue 31
Bioventus Financials
Summary Financials
- Revenue (Q2, 2024)
- $151.2M
- Gross profit (Q2, 2024)
- $103.6M
- Net income (Q2, 2024)
- ($32.1M)
- Cash (Q2, 2024)
- $32.0M
- EBIT (Q2, 2024)
- ($29.4M)
- Enterprise value
- $1.1B